SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kurnick NB. Autonomic hyperreflexia and its control in patients with spinal cord lesions. Ann Inter Med 1956; 44: 67886
  • 2
    Johnson B, Thomason R, Pallares V, Sadove MS. Autonomic hyperreflexia. Rev Milit Med 1975; 140: 3459
  • 3
    Kursch ED, Freehafer A, Persky L. Complications of autonomic dysreflexia. J Urol 1977; 118: 702
  • 4
    Giuliani S, Maggi CA, Meli A. Capsaicin-sensitive afferents in the rat urinary bladder activate a spinal sympathetic cardiovascular reflex. Naunyn-Schmiedeberg's Arch Pharmacol 1988; 338: 4116
  • 5
    Fowler CJ, Beck RO, Gerrard S, Betts CD, Fowler CG. Intravesical capsaicin for treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry 1994; 57: 16973
  • 6
    Geirsson G, Fall M, Sullivan L. Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hyperreflexia. J Urol 1994; 154: 18259
  • 7
    De Ridder D, Chadiramani V, Dasgupta P, Poppel HV, Baert L. Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup. J Urol 1997; 158: 208792
  • 8
    De Seze M, Wiart L, Joseph P-A, Dosque J-P, Mazaux J-M, Barat M. Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn 1998; 17: 51324
  • 9
    Cruz F, Guimaraes M, Silva C, Rio ME, Coimbra A, Reis M. Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction. J Urol 1997; 157: 5859
  • 10
    Cruz F, Guimaraes M, Silva C, Reis M. Suppression of bladder hyperreflexia by intravesical resiniferatoxin [letter]. Lancet 1997; 350: 6401
  • 11
    Lazzeri M, Beneforti P, Turini D. Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor. J Urol 1997; 158: 20936
  • 12
    Szallasi A. Vanilloid receptor ligands. hopes and realities for the future. Drugs Aging 2001; 18: 56173
  • 13
    Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levin JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 81624
  • 14
    Mezey E, Toth ZE, Cortright DN et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Prec Natl Acad Sci USA 2000; 97: 365560
  • 15
    Cortright DN, Crandall M, Sanchez JF et al. The tissue distribution and functional characterization of human VR1. Biochem Biophys Res Comm 2001; 281: 11839
  • 16
    Birder LA, Kanai AJ, De Groat WC et al. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 2001; 98: 13396401
  • 17
    Yiangou Y, Facer P, Ford A et al. Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder. BJU Int 2001; 87: 7749
  • 18
    Fagius J, Karhuvaara S. Sympathetic activity and blood pressure increases with bladder distension in humans. Hypertension 1989; 14: 5117
  • 19
    Cheng C-L, Ma C-P, De Groat WC. Effects of capsaicin on micturition and associated reflexes in rats. Am J Physiol 1993; 265: R132R138
  • 20
    Chuang Y-C, Fraser MO, Yu Y et al. Analysis of the afferent limb of the vesicovascular reflex using neurotoxins, resiniferatoxin and capsaicin. Am J Physiol 2001; 281: R1302R1310
  • 21
    Mathias CJ, Christensen NJ, Corbett JL, Frankel HL, Spalding JMK. Plasma catecholamines during paroxysmal neurogenic hypertension in quadriplegic man. Cir Res 1976; 39: 2048